Literature DB >> 1354008

Glutamate-immunoreactive synapses on retrogradely-labelled sympathetic preganglionic neurons in rat thoracic spinal cord.

I J Llewellyn-Smith1, K D Phend, J B Minson, P M Pilowsky, J P Chalmers.   

Abstract

Retrograde tracing with cholera toxin B subunit (CTB) combined with post-embedding immunogold labelling was used to demonstrate the presence of glutamate-immunoreactive synapses on sympathetic preganglionic neurons that project to the adrenal medulla or to the superior cervical ganglion in rat thoracic spinal cord. At the electron microscope level, glutamate-immunoreactive synapses were found on retrogradely labelled nerve cell bodies and on dendrites of all sizes. Two-thirds of the vesicle-containing axon profiles that were directly apposed to, or synapsed on, CTB-immunoreactive sympathoadrenal neurons were glutamate positive. The proportion of glutamate-immunoreactive contacts and synapses on sympathoadrenal neurons decreased to zero when the anti-glutamate antiserum was absorbed with increasing concentrations of glutamate from 0.1 mM to 10 mM. Double immunogold labelling for glutamate and gamma-aminobutyric acid (GABA) showed that glutamate-immunoreactive profiles did not contain GABA and that GABA-immunoreactive profiles did not contain glutamate. These results suggest that glutamate is the major excitatory neurotransmitter to sympathoadrenal neurons and possibly to other sympathetic preganglionic neurons in the intermediolateral cell column of the spinal cord.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1354008     DOI: 10.1016/0006-8993(92)90345-a

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  Physical (in)activity-dependent structural plasticity in bulbospinal catecholaminergic neurons of rat rostral ventrolateral medulla.

Authors:  Nicholas A Mischel; Ida J Llewellyn-Smith; Patrick J Mueller
Journal:  J Comp Neurol       Date:  2014-02-15       Impact factor: 3.215

2.  Medullary-evoked EPSPs in neonatal rat sympathetic preganglionic neurones in vitro.

Authors:  S A Deuchars; S F Morrison; M P Gilbey
Journal:  J Physiol       Date:  1995-09-01       Impact factor: 5.182

3.  Bilaterally evoked monosynaptic EPSPs, NMDA receptors and potentiation in rat sympathetic preganglionic neurones in vitro.

Authors:  D Spanswick; L P Renaud; S D Logan
Journal:  J Physiol       Date:  1998-05-15       Impact factor: 5.182

4.  Type I and II metabotropic glutamate receptor agonists and antagonists evoke cardiovascular effects after intrathecal administration in conscious rats.

Authors:  X C Li; P M Beart; J A Monn; N M Jones; R E Widdop
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

5.  The effect of nitric oxide on the efficacy of synaptic transmission through the chick ciliary ganglion.

Authors:  T R Scott; M R Bennett
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

6.  Plasticity of lumbosacral propriospinal neurons is associated with the development of autonomic dysreflexia after thoracic spinal cord transection.

Authors:  Shaoping Hou; Hanad Duale; Adrian A Cameron; Sarah M Abshire; Travis S Lyttle; Alexander G Rabchevsky
Journal:  J Comp Neurol       Date:  2008-08-01       Impact factor: 3.215

Review 7.  Different types of centrally acting antihypertensives and their targets in the central nervous system.

Authors:  P A van Zwieten; J P Chalmers
Journal:  Cardiovasc Drugs Ther       Date:  1994-12       Impact factor: 3.727

8.  Nitric Oxide Orchestrates a Power-Law Modulation of Sympathetic Firing Behaviors in Neonatal Rat Spinal Cords.

Authors:  Chun-Kuei Su; Yi-Yin Chen; Chiu-Ming Ho
Journal:  Front Physiol       Date:  2018-03-06       Impact factor: 4.566

9.  Neuroprotective Effect of Curcumin on the Nigrostriatal Pathway in a 6-Hydroxydopmine-Induced Rat Model of Parkinson's Disease is Mediated by α7-Nicotinic Receptors.

Authors:  Eslam El Nebrisi; Hayate Javed; Shreesh K Ojha; Murat Oz; Safa Shehab
Journal:  Int J Mol Sci       Date:  2020-10-03       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.